Salute e Benessere
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe
Copenhagen, Denmark – 7 July 2025: Europe is on the verge of a job and growth boom if biosolutions are prioritized and supported by the right policy framework. That is the conclusion in a new report by Amsterdam Data Collective (ADC), which for the first time quantifies the economic potential of the biosolutions sector in Europe, individual member states and globally.
According to the report, the biosolutions industry could create more than 600,000 direct and indirect jobs in Europe by 2035—nearly the equivalent of the entire population of Luxembourg. In just a decade, the total economic gain could reach EUR 133 billion, with EUR 46 billion in direct value - or the same as the combined annual contributions from France, Italy and Spain to the EU budget.
In addition, the analysis shows that each job in biosolutions generates nearly three additional jobs across other industries in Europe.
As countries worldwide ramp up policy support and investments in biosolutions, Europe has a unique position to lead the charge and strengthen its competitiveness. Industry leaders are calling for immediate action to ensure that Europe gets the right political framework to fully realize its potential.
y a stronger ecosystem where the next wave of biosolutions companies can thrive and scale,
As the global race for leadership in biosolutions intensifies, speed is becoming a decisive currency.
Today, approval for a novel protein can take up to three years in the EU. This is far longer than in faster-moving markets like Singapore, where it takes just four to six months. In the US and Brazil, new biopesticides are typically approved within two to three years—compared to six to eight years in the EU.
Brazil, too, has introduced a new bioinput law to fast-track commercial use of biosolutions—making it easier to adopt more sustainable practices across agriculture, livestock, aquaculture, and forestry.
As countries move quickly, backing innovation with significant investments and streamlined regulatory processes, Europe risks becoming the world’s best lab for solutions that scale elsewhere unless better regulation creates faster pathways from lab to market.
says Sofie Carsten Nielsen, Director of the European Biosolutions Coalition.
The report estimates that biosolutions could inject over EUR 877 billion into the global economy and generate more than five million jobs by 2035. These figures highlight the urgent need for Europe to capitalize on this momentum.
Biosolutions play a crucial role in solving some of the world’s most urgent crises and pave the way for new business models. Using microbes, enzymes, and other proteins as building blocks, biosolutions help businesses reduce waste, save energy and water, cut dependence on fossil resources, and develop innovative and profitable products. Biosolutions are already used across more than 30 industries, from preventive health and industrial applications to agriculture and food production.
The report is developed by Amsterdam Data Collective (ADC) and commissioned by Novonesis. The analyses in the report were carried out by ADC with input from experts in the biosolutions field including DI Biosolutions, the European Biosolutions Coalition, the International Advisory Council on Global Bioeconomy, Novonesis, and the World Economic Forum Bioeconomy Initiative and the support of policy knowledge partners Dragoman and Szpirt &Co.
(2024)
(2035)
(2024)
(2035)
Jens Gamborg, Head of External Communications, Novonesis: +45 3077 7182 / media-relations@novonesis.com
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti